Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

Bio-Rad Laboratories logo
$250.08 0.00 (0.00%)
As of 07/3/2025

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Key Stats

Today's Range
$250.08
$250.08
50-Day Range
$223.15
$250.08
52-Week Range
$225.29
$359.22
Volume
7 shs
Average Volume
28 shs
Market Capitalization
$6.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BIO.B Stock News Headlines

Bio-Rad Labs B (BIOb) Earnings Dates & Reports
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Bio-Rad price target lowered to $409 from $430 at RBC Capital
Bio-Rad price target lowered to $447 from $477 at RBC Capital
See More Headlines

BIO.B Stock Analysis - Frequently Asked Questions

Bio-Rad Laboratories' stock was trading at $325.60 on January 1st, 2025. Since then, BIO.B shares have decreased by 23.2% and is now trading at $250.08.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) issued its quarterly earnings data on Thursday, May, 1st. The company reported $2.54 earnings per share (EPS) for the quarter. The business had revenue of $585.40 million for the quarter. Bio-Rad Laboratories had a positive trailing twelve-month return on equity of 4.32% and a negative net margin of 85.16%.

Bio-Rad Laboratories subsidiaries include Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and others.

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/01/2025
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
Employees
8,200
Year Founded
1952

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.84 billion
Pretax Margin
-108.23%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$10.39 per share
Price / Cash Flow
24.06
Book Value
$234.52 per share
Price / Book
1.07

Miscellaneous

Free Float
19,490,000
Market Cap
$6.80 billion
Optionable
Not Optionable
Beta
0.81

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:BIO.B) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners